( neonatal drug wit hdrawal syndrome) ,,, 3 %, 50 % [1 5 ], 3 % 11 % 5 % [6 ] Milhorn ,,, 55 % 94 % [1 ] ] A [ ] (2000)
|
|
- Baldwin Charles
- 7 years ago
- Views:
Transcription
1 Chin J Contemp Pediatr Vol. 2 No. 1 Feb [ ] ; [ ] R96 ;R996 [ ] A [ ] (2000) ( neonatal drug wit hdrawal syndrome) ( ) %11 % 3 % 50 % 5 ] 5 % [6 ] 1 ] Milhorn ] (1) 2 ] ; 1 ] 11 ] ] ] ; 5 ] 221 ] 55 %94 % ] [ ] 1956 [ ]
2 2 1 (morphine) (methadone) (codeine) (pethidine) (heroin) (fentynal) (propoxyphine) (hydromorphone) (oxcodone) (pentazocine) (buprenorphine) (nalbuphine) (butorphanol) (phenobarbital) (amobarbital) (secobarbital) (diazepam) (oxazepam) (flurazepam) (estazolam) (chlordiazepoxide) (methaqualone) (glutethimide) (methyprylon) (ethchlorvynol) (ethinamate) (chloral hydrate) (bromide) (meprobamate) (impramine) (clomipramine) (desipramine) (hydroxyzine) (doxepin) (haloperid) (marijuana) (hashish) (lysergic acid diethylamine) ( psilocyn) (psilocybin) ( dimethyl2 tryptamine) (diethyltryptamine) (mescaline) (peyote) ( methylenedioxyamphetamine ) ( methoxy2 dimethylenedioxyamphetamine) (dimethylenedioxy - methamphetamine) (dimethylenedioxyethamphetamine) (nitrites) (nitrous oxide) (amphetamine) (dextroamphetamine) (methamphetamine) (benzphetamine) (diethylpropion) (fenfluramine) (mazindol) (phentermine) (phenypropanolamine) (phenmetrazine) (phendimetrazine) ( cocaine ) ( coffeine ) ( pemoline ) ( phencyclidines) (methylphenidate) 5 11 ] ] ; ( ) ( ) 3 ( ) ; ] ] 312h ; 4872 h ] 4 ; 47 d 114 d ; 12 d 58
3 1 : 21 ; 5 11 ] : : ; ; : ] : 9 20 ] ] 5 ] : : : : : : 5 11 ] : : 3. 3 : 1 Finnegan 31 ] : [9 Ostrea 6 ] : ] [22 Lipsitz 11 ] (2) : ( ) 8 < : > 4 ( 77 %) ; 59
4 ] cal/ kg 8 ] ] ] ] ] 11 ] ] Finnegan (tincture of opium) 2 ] ] 10 mg/ ml [22 ] mg/ kg ] / ] ; ] : 25 (0. 4 mg/ ml) mg/ kg ] (paregoric)
5 1 : mg/ ml 25 ] 13d 1 : (isoquinoline) (phenobarbital) (noscapine) (papaverine) ; (camphor) ; ; 11 (ethanol) ] 16 mg/ (anise oil) ; (benzyl alcohol) ( benzoicacid) 510 mg/ kg 24 h 46 mg/ kg 24 h 2345 d 72 h 15 % ( morphine) 13 mg/ kg [23 ] 10g/ ml (sodium bisulfite) (phenol) (diazepam) 2mg/ ml 4mg/ ml [8 ] ] : 10 % 1 ; ; ] (propylene glycol) (chlorpromazine) (methadone) mg/ kg 6 8 % 1 26h ] mg/ kg mg/ kg mg/ [24 25 kg ] (clonidine) 2 ] mg/ kg 35 mg/ kg ng/ ml ] kg 1520g/ ml mg/ kg 8 1 (sodium sulfite) ] 5 8 ]
6 2 6 / 330. / [2730 ] [ ] ] American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics 1998 ; 101 : [2 ] Substance Abuse and Mental Health Services Administration Of2 fice of Applied Studies Preliminary results from the 1996 national household servey on drug abuse Washington DC : US Dept of Health and Human Service [ 3 ] Milhorn HT Pharmacologic management of acute abstinence syn2 droms. Am Fam Physician 1992 ; 45 : [ 4 ] Khalsa J H Gfroerer J Epidemiology and health consequences of drug among pregnant woman Semin Perinatol 1991 ; 15 : ] Bean X Maternal substance abuse. In. Taeusch HW Ballard RA Avery ME. eds. Schaffer and Avery s Disease of the newborn 6th ed. Philadelphia : Saunders : [6 ] Kiegman RM Behrman RE. Substance abuse and withdrawals. In. Behrman RE Kliegman RM Nelson WE et al. Eds. Nel2 son Textbook of Pediatrics 14 thed : Philadelphia : saunders. [ 7 ] Rosenberg AA Battaglia FC. Infants of mothers who abuse drugs. In. Hathaway WE Groothuis J R Hay Jr WW et al. Current Pe2 diatric Diagnosis & Treatment 10th ed. Norwalk Connecticut Cali2 fornia : Appleton & Lange : [8 ] Pildes RS Srinivasan G. Infants of drug - dependent mothers. In. Gellis SS Kagan BM. eds. Current Pediatric Therapy Vol 13 Philadelphia : Saunders : [9 ] Ostrea EM. Infants of drug - dependent mothers. In. Burg FD Ingelfinger J R Wald ER. eds. Current Pediatric Therapy Vol : ] Committee on Substance Abuse Academy of Pediatrics. Sub2 stance abuse Pediatrics 1990 ; 86 : [ 11 ] Finnegan L P Neonatal abstinece. In. Nelson NM. Ed. Current Therapy in Neonatal - Perinatal Medicine. Toronto : BC Deck2 er : ] Finnegan L Kaltenbach K Weiner S et al. Neonatal cocaine 62 exposure assessment of risk scale. Pediatr Res : 10A. 3 ] Ryan RM Wagner CL Schultz J M et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr 1994 ; 125 : ] Horowitz RM Drug use in pregnancy : to test to tell : Legal implications for the physician. Semin Perinatol 1991 ; 15 : 324 [ 15 ] King TA Perlman J M Laptook AR ed. Neurologic manifesta2 tions of in utero cocaine exposure in near - term and term in2 fants. Pediatrics 1995 ; 96 : ] Napiorkowski B Lester BM Freier MC et al. Effects of in utero substances exposure on infant neurobehavior Pediatrics 1996 ; 98 : [ 17 ] Tromick EZ Frand DA Cabral H et al. Late dose - responds of prenatal cocaine exposure on newborn neurobehavioral perfor2 mance Pediatrics 1996 ; 98 : [ 18 ] Mayer LC granger RH Frank M et al. Neurobehavioral Pro2 files of neonates exposed to cocaine prenatally. Pediatrics 1993 ; 91 : ] Singer L Arendt R Minnes S. Neurodevelopmental effects of cocaine. Clin Perinatol 1993 ; 20 : [ 20 ] Zuckerman B Bresnahan K. Developmental and behavioral con2 sequences of drug and alcohol exposurs. Pediatr Chin North Am 1991 ; 38 : [ 21 ] Behnke M Eyler FD Conlon M et al. Incidence and descrip2 tion of structual brain abnormalities in newborn exposed to co2 caine. J Pediatr 1998 ; 132 : [22 ] Lipsitz PJ. Aproposed narcotic withdrawal score for use with newborn infants. a pragmatic evaluation of its efficacy. Clin Pe2 diatr 1975 ; 14 : [ 23 ] Wijburg FA Kleine MJ Fleury P et al. Morphine as an anti - epileptic drug in neonatal abstinence syndrome. Scand ; 80 : Acta Pediatr [24 ] Anand KJ Amold J H. Opioid tolerance and dependence in in2 fants and children. Crit Care Med 1994 ; 22 : [ 25 ] Tobias JD Schieien CL Haun SE. Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit pa2 tients. Crit Care Med 1990 ; 18 : [ 26 ] Baumgartner GR Rowen RC. Transdermal clonidine versus chlor2 diazepam in alcohol withdrawal : a randomized controlled clinical tri2 al. South Med J 1991 ; 84 : [ 27 ] Ashery R Robertson E Kumpfer KL. eds. Drug Abuse Prevention Trough Family Intervention. Rockville MD : NIH Pub [ 28 ] Johnson JL Leff M. Children of substance abusers : Overview of research findings. Pediatrics 1999 ; 103 : [29 ] Werner MJ Joffe A Graham AV. Screening early identification and office - based intervention with children and youth living in sub2 stance - abusing families. Pediatrics 1999 ; 103 : [ 30 ] Kumpfer KL. Outcome measures of interventions in the study of children of substance - abusing parents. Pediatrics 1999 ; 103 : ( : : ) ( : )
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010
Current Trends In Identifying And Treating Newborns With Withdrawal Syndromes 6/24/2010 Substance Exposed Newborns Alcohol Tobacco Caffeine Amphetamines Cocaine Barbituates Selective Serotonin Re-uptake
More informationNEONATAL ABSTINENCE SYNDROME. Osama Naga, M.D. PGY2
NEONATAL ABSTINENCE SYNDROME Osama Naga, M.D. PGY2 Objective: Describe the common causes of NAS Clinical Presentation Diagnosis Identify the different scoring system for pharmacologic therapy Minimize
More informationSubstance Use Guideline 4B PERINATAL OPIOID EXPOSURE, CARE OF THE NEWBORN
British Columbia Reproductive Care Program Substance Use Guideline 4B PERINATAL OPIOID EXPOSURE, CARE OF THE NEWBORN INTRODUCTION During the antenatal period, the opportunity exists for the primary care
More informationToxicology CPT Code Changes for 2016
Beginning January 1, 2016, CMS deleted all 2015 drug testing G codes and will continue to not recognize the AMA CPT codes for drug testing. CMS created three G codes for presumptive testing and four G
More informationNEONATAL ABSTINENCE SYNDROME AND SCORING SYSTEM
VIDANT MEDICAL CENTER PATIENT CARE _ SUBJECT: Abstinence Scoring NUMBER: A-1 PAGE: 1 OF: 5 _ NEONATAL ABSTINENCE SYNDROME AND SCORING SYSTEM POLICY: A thorough evaluation of the infant is required in order
More informationManagement of Pregnancy. Opioid Addiction Treatment
Management of Pregnancy Opioid Addiction Treatment Perinatal Opioid Addiction Pharmacotherapy and co-ordination of care are essential elements in the comprehensive care of pregnant patients with opioid
More informationIdentifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -2/11/13
Identifying Neonatal Abstinence Syndrome (NAS) and Treatment Guidelines University of Iowa Children s Hospital -// What is Neonatal Abstinence Syndrome? Neonatal withdrawal after intrauterine exposure
More informationManagement of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal
Management of Neonatal Abstinence Syndrome and Iatrogenic Drug Withdrawal Kirsten H. Ohler, Pharm.D., BCPS Clinical Assistant Professor Neonatal / Pediatric Clinical Pharmacist University of Illinois at
More informationOpiate treatment for opiate withdrawal in newborn infants (Review)
(Review) Osborn DA, Jeffery HE, Cole MJ This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2010, Issue 10 http://www.thecochranelibrary.com
More informationNeonatal Abstinence Syndrome: Indian Health Service (IHS) Best Practices Guidelines
Neonatal Abstinence Syndrome: Indian Health Service (IHS) Best Practices Guidelines 1. Neonatal Drug Withdrawal Intrauterine exposure to certain drugs and medications can cause clinical symptoms in the
More informationMethadone and Pregnancy
Methadone and Pregnancy Methadone 101/Hospitalist Workshop Launette Rieb, MD, MSc, CCFP, CCSAM, FCFP Clinical Associate Professor, Dept. Family Practice, UBC American Board of Addiction Medicine Certified
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationMethadone and Pregnancy Updated June 26, 2007
Methadone and Pregnancy Updated June 26, 2007 GENERAL INFORMATION About Methadone (2006) Drug Policy Alliance http://www.drugpolicy.org/docuploads/aboutmethadone.pdf Methadone Maintenance Treatment (February
More informationPregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research
Pregnancy and Addiction: A World View of the Problem, Current Treatments and Future Research Hendree E. Jones Associate Professor, Department of Psychiatry Johns Hopkins University Outline I. World view
More information(peak at 2 days 6 wks)
Perinatal Manual of Southwestern Ontario A collaboration between the Regional Perinatal Outreach Program of Southwestern Ontario & the Southwestern Ontario Perinatal Partnership (SWOPP) Chapter 46 NEONATAL
More informationV11.2 NPIC/QAS. Special Quarterly Report: Linked Analysis Neonatal Abstinence Syndrome
V11.2 NPIC/QAS Special Quarterly Report: Linked Analysis Neonatal Abstinence Syndrome I. Background The use of drugs and alcohol during pregnancy has been shown in several studies to affect the health
More informationNeonatal Drug Withdrawal. John Wareham, MD Department of Neonatology, St. Vincent Women s Hospital
Neonatal Drug Withdrawal John Wareham, MD Department of Neonatology, St. Vincent Women s Hospital Neonatal Drug Withdrawal What are we going to cover? Overview of the problem in neonates Opioid exposure/dependence
More informationSouth Carolina Drug Statutes South Carolina Code of Laws: Title 44 Health Code
SCHEDULE CRITERIA AND COMPOSITION SCHEDULE I: (a) A high potential for abuse; (b) No accepted medical use in treatment in the United States; (c) A lack of accepted safety for use in treatment under medical
More informationMarch of Dimes. FAQ on Drug Use and Pregnancy. November 2006. <http://www.marchofdimes.com/14332_1169.asp>. [accessed February 2010]
March of Dimes. FAQ on Drug Use and Pregnancy. November 2006. . [accessed February 2010] After delivery, babies who were exposed to amphetamines before birth
More informationSubstance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
More informationAddressing Substance Use in Pregnancy
Addressing Substance Use in Pregnancy Stefan Maxwell, MD Director, NICU, CAMC Women and Children s Hospital Chair, Drug Use in Pregnancy Committee West Virginia Perinatal Partnership July 31, 2013 WV Early
More informationMassachusetts Department of Public Health Guidelines for Community Standard for Maternal/Newborn Screening For Alcohol/Substance Use
The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619 DEVAL L. PATRICK GOVERNOR TIMOTHY P. MURRAY LIEUTENANT
More informationWITHDRAWAL OF ANALGESIA AND SEDATION
WITHDRAWAL OF ANALGESIA AND SEDATION Patients receiving analgesia and/or sedation for longer than 5-7 days may suffer withdrawal if these drugs are suddenly stopped. To prevent this happening drug doses
More informationIntroduction to Neonatal Abstinence Syndrome
Introduction to Neonatal Abstinence Syndrome Cara Christ, MD Director, Arizona Department of Health Services Learning Objectives 1.Define Neonatal Abstinence Syndrome 2.Describe Neonatal Abstinence Syndrome
More informationAn Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse
Drug Testing An Overview of Mayo Clinic Tests Designed for Detecting Drug Abuse Printed on August 18, 2016 1:59 pm CST 2016 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.
More informationSMART DISCHARGE. Client s Name: Client ID: Partial Hospitalization Clinically Managed Medium Intensity Residential Treatment
SMART DISCHARGE Client s Name: Client ID: DATE OF DISCHARGE: Reason for Discharge Completed Treatment no further treatment needed Completed Treatment Plan/Referred Incomplete Client Left Before Completing
More informationNNEPQIN Guideline for the Management of Labor, Delivery and the Newborn in the Opioid Dependent Pregnancy. March 2014
The following guidelines are intended only as a general educational resource for hospitals and clinicians, and are not intended to reflect or establish a standard of care or to replace individual clinician
More informationWelcome. How Do I Ask Questions? Agenda. Thank you for joining us today. The webinar will begin in a few moments.
Welcome How Do I Ask Questions? Thank you for joining us today. The webinar will begin in a few moments. If you are experiencing technical problems with the GoToWebinar program, contact the GoToWebinar
More informationOklahoma Drug Statutes Chart Oklahoma Statutes Title 63 Public Health and Safety SCHEDULE OFFENSE/PENALTY ENHANCEMENT/ BENEFIT RESTRICTIONS
SCHEDULE OFFENSE/PENALTY ENHANCEMENT/ BENEFIT RESTRICTIONS 2-203. Schedule I Characteristics: (1) High potential for abuse; (2) No accepted med use in US or lacks accepted safety for use in treatment under
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationKarol Kaltenbach, PhD Maternal Addiction Treatment Education and. Jefferson Medical College Thomas Jefferson University
Benzodiazepines and the Pregnant Patient: Special Challenges Karol Kaltenbach, PhD Maternal Addiction Treatment Education and Research Jefferson Medical College Thomas Jefferson University Outline Introduction
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationSubstance-Exposed Newborns
Substance-Exposed Newborns State of Oklahoma 2013 Substance-Exposed Newborns State of Oklahoma 2013 Legal Background Federal guidelines in the Child Abuse Prevention and Treatment Act (CAPTA) require states
More informationDRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation.
More informationNarcotic Withdrawal Syndrome Neonatal Abstinence Syndrome
Narcotic Withdrawal Syndrome Neonatal Abstinence Syndrome Henrietta S. Bada, MD, MPH Mary Florence Jones Professor of Pediatrics Chief, Division of Neonatology University of Kentucky Public Health Perspective
More informationa. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes einforcement
Drug Abuse (chapter 18) 1. Definitions iti a. positive vs. negative reinforcement b. tolerance vs. sensitization c. drug classes 2. Neural Mechanisms of Re einforcement a. mesolimbic dopamine system b.
More informationChildren s Specialized Hospital Neonatal Abstinence Syndrome (NAS)
Children s Specialized Hospital Neonatal Abstinence Syndrome (NAS) A Pharmacologic and Rehabilitation Program that Promotes Narcotic Weaning and Autonomic Regulation Necessary for Infant Development Sharon
More information2013 Transforming Neonatal Drug Withdrawal
2013 Transforming Neonatal Drug Withdrawal Carl R. Backes, DO Director, Neonatal Abstinence Clinic Nationwide Children s Hospital Clinical Assistant Professor, The Ohio State University How Big is the
More informationDrug & Alcohol Policy August 2015
Drug & Alcohol Policy August 2015 DRUG-FREE SCHOOL AND WORKPLACE STATEMENT In accordance with the Drug-Free Schools and Communities Act amendments of 1989, Public Law 101-226, Hussian College - School
More informationEstablished in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay.
Established in 1974 Non-Profit Federal Block Grant recipient Accept Medicaid, Private Insurance, and Self-Pay. Patients are not denied treatment if they do not have the ability to pay for services Schedule
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationSubstance Abuse During Pregnancy
Substance Abuse During Pregnancy Time for Policy to Catch up with Research Barry M. Lester, Ph.D. Infant Development Center, Brown Medical School National Conference of State Legislators Audio Conference
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationOU MEDICAL CENTER Human Resource Policy and Procedure Manual. Subject: Drug and Alcohol
OU MEDICAL CENTER Human Resource Policy and Procedure Manual Subject: Drug and Alcohol Section: HR 6-10 Page: 1 of 5 Origination Date: 6/2004 Revision Date: 2/2006, 9/2008, 7/2009 Coverage: All OUMC employees
More informationClonidine for Opioid Related Neonatal Abstinence Syndrome: Is Clonidine the New Alpha-Male of Adjunct?
Clonidine for Opioid Related Neonatal Abstinence Syndrome: Is Clonidine the New Alpha-Male of Adjunct? Learning Objectives Marc Flynt, PharmD Children s Hospital of San Antonio, San Antonio, TX Division
More informationHow To Know If A Baby Is A Drug Addict
AMERICAN ACADEMY OF PEDIATRICS Committee on Drugs Neonatal Drug Withdrawal ABSTRACT. Maternal drug use during pregnancy may result in neonatal withdrawal. This statement presents current information about
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationAlcohol and Drug. A Cochrane Handbook. losief Abraha MD. Cristina Cusi MD. Regional Health Perugia
Alcohol and Drug A Cochrane Handbook losief Abraha MD Regional Health Perugia of Cristina Cusi MD Outpatient Services - Neurology Clinical Institutes of Specialisation Milan Italy A John Sons, Ltd., THE
More informationDrug-related hospital stays in Australia 1993 2009
in Australia 1993 29 Prepared by Funded by Amanda Roxburgh and Lucy Burns, National Drug and Alcohol Research Centre the Australian Government Department of Health and Ageing Recommended Roxburgh, A.,
More informationSUPPORTING WOMEN USING OPIATES IN PREGNANCY: A Guideline for Primary Care Providers May, 2011
INTRODUCTION SUPPORTING WOMEN USING OPIATES IN PREGNANCY: A Guideline for Primary Care Providers May, 2011 Prevalence of Opiate Use and Impact on Maternal, Fetal, and Neonatal Health: The prevalence of
More informationTests Impacted by 2015 CPT Changes
Toxicology Changes for 2015 HPV Examples of Toxicology Panels Molecular Pathology, FISH and Anatomic Pathology 1 Toxicology Changes for 2015 80100 Test Code Dos Test Name 2015 2015 Medicare 5229 Drug Screen,
More information1. Carrying Personal Medications into Thailand A. Medications containing narcotic drugs of category 2
Guidance for Travellers to Thailand under Treatment Carrying Personal Medications Containing Narcotic Drugs/Psychotropic Substances into/out of Thailand This guidance issued by the Narcotics Control Division,
More informationFDA Presentation: Maternal Perspective on Opioid Medication Assisted Therapy
FDA Presentation: Maternal Perspective on Opioid Medication Assisted Therapy Lorraine A. Milio, M.D. Obstetrical Director Center for Addiction and Pregnancy Assistant Professor Maternal-Fetal Medicine
More informationMarijuana Use Among Pregnant Women in Buprenorphine Treatment for Opioid Dependence
University of Vermont ScholarWorks @ UVM Family Medicine Clerkship Student Projects College of Medicine 2014 Marijuana Use Among Pregnant Women in Buprenorphine Treatment for Opioid Dependence Tara Higgins
More informationImpact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol
More informationCONSEQUENCES AND SANCTIONS FOR POLICY VIOLATIONS
OREGON INSTITUTE OF TECHNOLOGY Controlled Substance Policy OIT is committed to maintaining a workplace and educational environment free from unlawful manufacture, possession, distribution, and/or use of
More informationIdentifying and Managing Substance Use During Pregnancy
Identifying and Managing Substance Use During Pregnancy Joseph B. Landwehr, Jr., MD Director, Perinatal Center IU Health Ball Memorial Hospital OBJECTIVES Overview of illicit drug use in pregnant women
More informationOpiate treatment for opiate withdrawal in newborn infants (Review)
(Review) Osborn DA, Jeffery HE, Cole MJ This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library 2009, Issue 1 http://www.thecochranelibrary.com
More informationNeonatal Abstinence Syndrome
Neonatal Abstinence Syndrome D COGHLAN, *M MILNER, T CLARKE, I LAMBERT, C MCDERMOT, M MCNALLY, M BECKETT. T MATTHEWS Department of Paediatrics and *Obstetrics. Rotunda Hospital. Parnell Square. Dublin
More informationIntrauterine exposure to drugs may lead to neonatal
AMERICAN ACADEMY OF PEDIATRICS Committee on Drugs Neonatal Drug Withdrawal ABSTRACT. Maternal drug use during pregnancy may result in neonatal withdrawal. This statement presents current information about
More information10/19/15. Stephen Loyd, M.D., F.A.C.P Healthy Kingsport Meadowview Convention Center Kingsport, Tennessee October 17, 2015
Stephen Loyd, M.D., F.A.C.P Healthy Kingsport Meadowview Convention Center Kingsport, Tennessee October 17, 2015 Receives no commercial support, in any form, from pharmaceutical companies or anyone else
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationSeveral studies have explored the impact of intrauterine
J Perinat Neonat Nurs Vol. 24, No. 4, pp. 366 372 Copyright c 2010 Wolters Kluwer Health Lippincott Williams & Wilkins Identifying Infants at Risk for Neonatal Abstinence Syndrome A Retrospective Cohort
More informationThe Effects Of Drug Abuse On Dialysis
DRUGS OF ABUSE IN THE DIALYSIS POPULATION 2 0 1 4 H E A R T L A N D K I D N E Y C O N F E R E N C E Jamie Killion, PharmD, BCPS MEDICAL I N FORMATION SPECIALIST OBJECTIVES: Describe the magnitude of drug
More informationFRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House
FRN Research Report February/March 2012: Treatment Outcomes for Prescription Drug Addiction at Michael s House Background While the use of illegal drugs like cocaine and heroin is falling, more people
More informationDrug Law Comparisons Charts of Southern States
Drug Law Comparisons Charts of Southern States Alabama, Arkansas, Florida, Georgia, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, and Texas Table of Contents Alabama... 3 Arkansas...
More informationNARCOTICS DEPRESSANTS DRUG CATEGORY PROFILES. Physical/Psychological High/High High/High. (hours) 3-6 3-6. Opium Morphine
DRUG CATEGORY PROFILES NARCOTICS Opium Morphine Codeine Heroin Hydromorphone Meperidine Methadone What are Narcotics? Indications of Possible Misuse DEPRESSANTS High/High High/High Mod./Mod. High/High
More informationNeonatal Abstinence Syndrome Anthony E. Burgos and Bryan L. Burke, Jr. DOI: 10.1542/neo.10-5-e222
Neonatal Abstinence Syndrome Anthony E. Burgos and Bryan L. Burke, Jr NeoReviews 2009;10;e222-e229 DOI: 10.1542/neo.10-5-e222 The online version of this article, along with updated information and services,
More informationClinic Reference Guide
Clinic Reference Guide 2010 Alliance Toxicology LLC PO Box 5000, PMB 190 Rancho Santa Fe, CA 92067 AllianceToxicologyLLCprovidesclinicaldrugtestingservicesforphysicians.Our companyprovidesacomprehensivedrugtestingpanelwhichincludesover40
More informationThe CCB Science 2 Service Distance Learning Program
S2S 2055 DETOXIFICATION Module 1 Post-Test 1. A common use of a biochemical marker is. a. to support or refute other information that leads to proper diagnosis b. for forensic purposes c. in detecting
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationNarcotic drugs used for pain treatment Version 4.3
Narcotic drugs used for pain treatment Version 4.3 Strategy to restrict the pack sizes or the type of packaging available in public pharmacies. 1. Introduction The document describing the strategy of the
More informationfor Management Guidelines Infants with Neonatal Abstinence Syndrome BACKGROUND DIFFERENTIAL DIAGNOSIS
Management Guidelines for Infants with Neonatal Abstinence Syndrome BACKGROUND Neonatal drug withdrawal can occur when newborn infants are exposed to medications or addictive substances in-utero, or can
More informationCHILDREN S SERVICES. Neonatal Abstinence Syndrome
CHILDREN S SERVICES Neonatal Abstinence Syndrome Background Neonatal Abstinence Syndrome (NAS) is a combination of behavioural and physiological signs and symptoms that occur in newborns going through
More informationCollaborative Care for Pregnant Women with Substance Use Disorders
Collaborative Care for Pregnant Women with Substance Use Disorders Alane O Connor DNP Maine Dartmouth Family Medicine Residency MaineGeneral Medical Center Dartmouth Medical School Vanderbilt University
More informationSubstance Abuse lifestyle Concern for mother - fetus - and - neonate
OBJECTIVES Learn about types of opioids and associated withdrawal symptoms Learn what medications are available to treat opioid addiction Understand the pros and cons associated with each medication Understand
More informationNeonatal Abstinence Syndrome: An Emerging Epidemic?
Neonatal Abstinence Syndrome: An Emerging Epidemic? March 11, 2013 Balaji Govindaswami, MD, MPH Chief Newborn Medicine, Director - NICU Santa Clara Valley Health and Hospital System, San Jose, CA Clinical
More informationNon-punitive Alcohol and Drug Treatment for Pregnant and Breast-feeding Women and their Exposed Children
Non-punitive Alcohol and Drug Treatment for Pregnant and Breast-feeding Women and their Exposed Children Date: December 9, 2011 Status: Originated by: Adopted by: Revised Position Statement ANA Center
More informationMEDICATION ABUSE IN OLDER ADULTS
MEDICATION ABUSE IN OLDER ADULTS Clifford Milo Singer, MD Adjunct Professor, University of Maine, Orono ME Chief, Division of Geriatric Mental Health and Neuropsychiatry The Acadia Hospital and Eastern
More informationCCW Task Order 16: Round 3 Clinical Condition Algorithms. Page 1 of 5 ICD-9 CODE DESCRIPTION ICD-9 CODE
DESCRIPTION 292 Drug-induced mental disorders 2920 Drug withdrawal 29211 Drug-induced psychotic disorder with delusions 29212 Drug-induced psychotic disorder with hallucinations 2922 Pathological drug
More informationBreastfeeding and Substance Abuse: What do we really know? IHS Best Practice Guidelines
Breastfeeding and Substance Abuse: What do we really know? IHS Best Practice Guidelines Anne Merewood PhD MPH IBCLC Consultant to the Indian Health Service Part 4 of our series Illicit Substance Use around
More informationNHS FORTH VALLEY Management of Neonatal Abstinence Syndrome
NHS FORTH VALLEY Management of Neonatal Abstinence Syndrome Date of First Issue 25/10/2011 Approved 25/11/2011 Current Issue Date 30/11/2011 Review Date 30/11/2013 Version 1.00 EQIA Yes 06/12/2011 Author
More informationGUIDELINES FOR THE MANAGEMENT OF THE INFANT WITH NEONATAL ABSTINENCE SYNDROME. Background IMPORTANCE OF EARLY RECOGNITION
Background GUIDELINES FOR THE MANAGEMENT OF THE INFANT WITH NEONATAL ABSTINENCE SYNDROME Neonatal Abstinence Syndrome (NAS) is a syndrome of drug withdrawal observed in infants of mothers physically dependent
More information2013 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS
Toxicology Program Trends 213 213 IDAHO STATE POLICE FORENSIC SERVICES: TOXICOLOGY TRENDS Overview and Background This report discusses trends in the toxicology program, as well as the number of toxicology
More informationSouth Dakota State University Statement on Illegal Drugs and Alcohol. Introduction. Policy. Disciplinary Sanctions
South Dakota State University Statement on Illegal Drugs and Alcohol Introduction This statement is provided to students, faculty and staff of South Dakota State University in compliance with the requirements
More informationThe Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures
The Clinical Content of Preconception Care: Alcohol, Tobacco, and Illicit Drug Exposures by R. Louise Floyd, DSN, RN; Brian W. Jack, MD; Robert Cefalo, MD, PhD; Hani Atrash, MD, MPH; Jeanne Mahoney, BSN,
More informationAmerican Society of Addiction Medicine
American Society of Addiction Medicine Public Policy Statement on Parity in Benefit Coverage: A Joint Statement by ASAM and AMBHA The American Managed Behavioral Healthcare Association (AMBHA) and the
More informationMANAGEMENT OF THE INFANT BORN TO THE DRUG-ABUSING MOTHER Version: 5 Ratification Date: Feb 2014 Review Date: Feb 2017 Approval:
Title: MANAGEMENT OF THE INFANT BORN TO THE DRUG-ABUSING MOTHER Version: 5 Ratification Date: Feb 2014 Review Date: Feb 2017 Approval: Nottingham Neonatal Service Clinical Guideline Meeting Author: Sara
More informationPrevention and Treatment of Opioid and Benzodiazepine Withdrawal
1.0 Introduction The purpose of this guideline is to ensure that patients who are at risk of developing withdrawal symptoms can be weaned off opioids and benzodiazepines in a timely fashion. It is appropriate
More informationA Review of the Impacts of Opiate Use in Ontario: Summary Report
A Review of the Impacts of Opiate Use in Ontario: Summary Report A Provincial Summary Report of the Impacts of the Discontinuation of Oxycontin in Ontario: January to August 2013 December 2013 This report
More informationAlgorithm for Initiating Antidepressant Therapy in Depression
Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationAMERICAN ACADEMY OF ADDICTION PSYCHIATRY
AMERICAN ACADEMY OF ADDICTION PSYCHIATRY BOARD OF DIRECTORS Michael H. Gendel, MD President Elinore F. McCance-Katz, MD, PhD President-Elect Joseph G. Liberto, MD Vice President Laurence M. Westreich,
More informationHeroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationPRENATAL DRUG USE AND NEWBORN HEALTH. Federal Efforts Need Better Planning and Coordination
United States Government Accountability Office Report to Congressional Requesters February 2015 PRENATAL DRUG USE AND NEWBORN HEALTH Federal Efforts Need Better Planning and Coordination GAO-15-203 Highlights
More informationPrescription Drugs: Abuse and Addiction
EAP Drug Free Workplace Newsletter March 2014 Prescription Drugs: Abuse and Addiction What are some of the commonly abused prescription drugs? Although many prescription drugs can be abused or misused,
More information